Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Concordia University

$25,000.00

Integrated microfluidics for screening thermo-resistant fungi**

FY 2018-19

Summary
Directed evolution is a technique used to artificially evolve strains to discover new and useful proteins. This technique has shown how rapidly some proteins can evolve under some strong selection pressures and have provided new insights into the relationship between sequence and function. Lallemand Inc., a privately-held Canadian company in Montreal, is a global leader in the development, production of yeast, bacteria, and specialty ingredients for human and animal nutrition as well as for the pharmaceutical industry. A current bottleneck in Lallemand's workflow is the automation capabilities for high-throughput screening and selection of microbial strains. The technological tools to perform such tasks are typically automated robotics with flow cytometry, which are usually cost-prohibitive and require large footprints. An alternative is to use a technology called microfluidics. Microfluidics, also known as ""lab-on-chip"", has been shown as an alternative to automated robotics and flow cytometry since it brings advantages of low-cost and benchtop-type footprint. In fact, microfluidics has been shown to be an efficient tool to directly evolve and to select strains of interest. In this proposal, the Shih lab (Concordia) and Lallemand Inc. are joining forces to use microfluidic-based technology to screen and to isolate thermo-resistant mutants of Clonostachys rosea. C. rosea is a biofungicide that colonizes on leaf and root surfaces and it is known to have inhibiting effects on nematodes and suppress fungal diseases. With this collaboration, we will be able to use developed microfluidic devices from the Shih lab to screen for C. rosea mutants to obtain a wealth of information on the mechanisms of adaptation and resistance that can be used to potentially develop novel pharmaceuticals. This is the first step towards rapid strain selection and engineering and if successful, it can possibly change the way Canadians create energy, produce food, to optimize industrial processing.*
Program
Engage Grants Program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
536856-2018
Name nom
Shih, Steve
Department département
Electrical and Computer Engineering
Organization id
70
Institution établissement
Concordia University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Integrated microfluidics for screening thermo-resistant fungi**
Keyword
NSERC
Application summary
Directed evolution is a technique used to artificially evolve strains to discover new and useful proteins. This technique has shown how rapidly some proteins can evolve under some strong selection pressures and have provided new insights into the relationship between sequence and function. Lallemand Inc., a privately-held Canadian company in Montreal, is a global leader in the development, production of yeast, bacteria, and specialty ingredients for human and animal nutrition as well as for the pharmaceutical industry. A current bottleneck in Lallemand's workflow is the automation capabilities for high-throughput screening and selection of microbial strains. The technological tools to perform such tasks are typically automated robotics with flow cytometry, which are usually cost-prohibitive and require large footprints. An alternative is to use a technology called microfluidics. Microfluidics, also known as ""lab-on-chip"", has been shown as an alternative to automated robotics and flow cytometry since it brings advantages of low-cost and benchtop-type footprint. In fact, microfluidics has been shown to be an efficient tool to directly evolve and to select strains of interest. In this proposal, the Shih lab (Concordia) and Lallemand Inc. are joining forces to use microfluidic-based technology to screen and to isolate thermo-resistant mutants of Clonostachys rosea. C. rosea is a biofungicide that colonizes on leaf and root surfaces and it is known to have inhibiting effects on nematodes and suppress fungal diseases. With this collaboration, we will be able to use developed microfluidic devices from the Shih lab to screen for C. rosea mutants to obtain a wealth of information on the mechanisms of adaptation and resistance that can be used to potentially develop novel pharmaceuticals. This is the first step towards rapid strain selection and engineering and if successful, it can possibly change the way Canadians create energy, produce food, to optimize industrial processing.*
Concordia University - $25,000 Grant (2018-19) | Canada Spends